Science Explorer Back to mapMap
Discussion
Researcher · Krankenhaus Barmherzige Brüder · Germany

Bernhard Heilmeier

Bernhard Heilmeier publishes mostly in Molecular Biology, Hematology and Oncology, on topics such as Acute Myeloid Leukemia Research, Multiple Myeloma Research and Treatments and Cancer-related gene regulation.

OpenAlex
World rank
#3,287,236
of 7,710,434 ranked researchers
Rank in Germany
#163,862
of 364,343
Works
39
Citations
868
Citations per work
22.3
h-index
16
i10-index 17Top 46% in Molecular Biology
Bernhard Heilmeier

What does Bernhard Heilmeier research?

Bernhard Heilmeier's work is mostly in Medicine (46%), Biochemistry, Genetics and Molecular Biology (27%), Immunology and Microbiology (5%).

Health Sciences: 18 works · 45.8% of their workMedicine: 18 works · 45.8% of their workHematology: 10 works · 25.5% of their workOncology: 5 works · 12.8% of their workCardiology and Cardiovascular Medicine: 2 works · 4.3% of their workGenetics: 1 works · 3.2% of their workLife Sciences: 12 works · 31.9% of their workBiochemistry, Genetics and Molecular Biology: 10 works · 26.6% of their workMolecular Biology: 10 works · 26.6% of their workImmunology and Microbiology: 2 works · 5.3% of their workImmunology: 2 works · 5.3% of their workEverything else: 9 works · 22.3% of their workTHEIR WORKBernhardHeilmeier39works
Life Sciences32%Health Sciences46%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1845.8%
    1. Biochemistry, Genetics and Molecular Biology1026.6%
    2. Immunology and Microbiology25.3%
  3. Everything else922.3%
  1. 1Molecular Biology27% of their works
  2. 2Hematology26% of their works
  3. 3Oncology13% of their works
  4. 4Immunology5% of their works
  5. 5Cardiology and Cardiovascular Medicine4% of their works
  6. 6Genetics3% of their works

Research topics

Which keywords describe Bernhard Heilmeier's research?

The keywords of their largest research topics: Acute Myeloid Leukemia, AML, Cancer, Diagnosis Criteria, International Myeloma Working Group, Transcriptional Regulation, Arginine Methylation and Protein Arginine Methyltransferases.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. AML111 topic
  2. Acute Myeloid Leukemia111 topic
  3. Cancer102 topics
  4. Diagnosis Criteria101 topic
  5. International Myeloma Working Group101 topic
  6. Transcriptional Regulation102 topics
  7. Arginine Methylation71 topic
  8. Protein Arginine Methyltransferases71 topic
  9. Fibroblast Activation Protein41 topic
  10. Tumor Microenvironment41 topic
  11. Acute Promyelocytic Leukemia31 topic
  12. Antimicrobial Agents31 topic
  13. BET Bromodomains31 topic
  14. Febrile Neutropenia31 topic
  15. PROTACs31 topic
  16. Retinoic Acid31 topic
  17. DNA Methylation21 topic
  18. Histone Modification21 topic

Where does Bernhard Heilmeier work?

Bernhard Heilmeier's main affiliation in the publication record is Krankenhaus Barmherzige Brüder, Germany.

How many publications and citations does Bernhard Heilmeier have?

OpenAlex counts 39 works and 868 citations for Bernhard Heilmeier, an h-index of 16, ranking #3,287,236 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Bernhard Heilmeier. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.